Crosstalk between microRNA-122 and FOX family genes in HepG2 cells

Subodh Kumar1, Ankita Batra1, Shruthi Kanthaje1

  • 1Department of Experimental Medicine and Biotechnology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.

Insights

MicroRNA-122 (miR-122) augmentation increases apoptosis in liver cancer cells. This involves the altered expression of key forkhead box (FOX) genes, suggesting a novel therapeutic target for hepatocellular carcinoma (HCC).

Area of Science:

  • Molecular Biology
  • Hepatology
  • Cancer Research

Background:

  • MicroRNA-122 (miR-122) is a liver-specific microRNA crucial for normal liver function and implicated in hepatocellular carcinoma (HCC).
  • Downregulation of miR-122 in HCC is linked to altered apoptosis, a key process in cancer development.
  • Forkhead box (FOX) family genes are known regulators of apoptosis and potential targets of miR-122.

Purpose of the Study:

  • To investigate the interplay between miR-122 and its target FOX family genes (FOXM1b, FOXP1, FOXO4) in the context of apoptosis.
  • To determine the effect of miR-122 augmentation on apoptosis and the expression of selected FOX genes in HCC cells.

Main Methods:

  • Transfection of HepG2 cells with miR-122 to augment its expression.
  • In silico analysis to identify miR-122 targets involved in apoptosis.
  • Quantitative analysis of FOXM1b, FOXP1, and FOXO4 gene expression at the transcript level post-transfection.

Main Results:

  • Transfection with miR-122 led to increased apoptosis in HepG2 cells.
  • FOXP1 and FOXM1b gene expression were significantly downregulated following miR-122 augmentation (p < 0.005).
  • FOXO4 gene expression was significantly upregulated following miR-122 augmentation (p < 0.005).

Conclusions:

  • Augmentation of miR-122 in liver cancer cells modulates apoptosis.
  • Deregulation of FOXM1b, FOXP1, and FOXO4 gene expression by miR-122 contributes to apoptosis modulation in HCC.
  • These findings suggest a potential therapeutic strategy targeting the miR-122/FOX gene axis in hepatocellular carcinoma.